Kupando

Developer of immunotherapeutics for cancer

placeSchonefeld, Brandenburg, Germany calendar_todayFounded 2018 groups5 employees language kupando.com

Registered entities

Social engagement

Social engagement: 552 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Remiges Ventures, LifeCare Partners.

Investor typeCountShare
Venture capital440%
Private equity110%
Other / undisclosed550%

Recent activity

3 Feb 2026
Leadership hire
Chair of its Board of Directors
Coming soon